Results of four different protocols for prophylaxis against graft-versus-host disease.
Tollemar
J
J
Department of Clinical Immunology, Karolinska Institute, Stockholm, Sweden.
Ringdén
O
O
Bäckman
L
L
Janossy
G
G
Lönnqvist
B
B
Markling
L
L
Philstedt
P
P
Sundberg
B
B
D000208:Acute Disease; D000328:Adult; D016026:Bone Marrow Transplantation; D002986:Clinical Trials as Topic; D003524:Cyclosporins / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006086:Graft vs Host Disease / Q000209:etiology / Q000401:mortality / Q000517:prevention & control*; D006801:Humans; D007938:Leukemia / Q000401:mortality / Q000601:surgery; D008212:Lymphocyte Depletion; D008223:Lymphoma / Q000401:mortality / Q000601:surgery; D008727:Methotrexate / Q000627:therapeutic use*; D011183:Postoperative Complications / Q000209:etiology / Q000401:mortality / Q000517:prevention & control; D011897:Random Allocation; D012008:Recurrence; D013601:T-Lymphocytes
D003524:Cyclosporins; D008727:Methotrexate